{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:12:21Z","timestamp":1780053141382,"version":"3.54.0"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.849119\/2023-00"],"award-info":[{"award-number":["88887.849119\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09684-9","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T10:03:20Z","timestamp":1758362600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associative study of human herpesvirus 8 and Kaposi\u2019s sarcoma: Mapping viral oncogenic properties and the clinical scenario in oncological patients"],"prefix":"10.1007","volume":"73","author":[{"given":"Jo\u00e3o Vitor Geisteira Oliveira","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Manya Bittencourt Dias","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eidy","family":"de Oliveira Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"9684_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/B978-0-12-803109-4.00034-9","volume-title":"Viruses: from understanding to investigation","author":"S Payne","year":"2017","unstructured":"Payne S. The Herpesviridae family. In: Payne S, editor. Viruses: from understanding to investigation. London: Academic Press; 2017. p. 269\u201378."},{"key":"9684_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF01317248","volume":"123","author":"B Roizman","year":"1992","unstructured":"Roizman B, Desrosiers RC, et al. The family Herpesviridae: an update. Arch Virol. 1992;123:425\u201349. https:\/\/doi.org\/10.1007\/BF01317248.","journal-title":"Arch Virol"},{"key":"9684_CR3","unstructured":"Santos MPM, Santos MPL, Morais DDD, Fonseca LMM, et al. Human herpes virus: types, oral manifestations and treatment. Odontol. Cl\u00edn.-Cient. (Online). 2012;11(3):263\u2013267. Available at: https:\/\/revodonto.bvsalud.org\/pdf\/occ\/v11n3\/v11n3a13.pdf."},{"issue":"8","key":"9684_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1086\/340041","volume":"185","author":"F Xu","year":"2002","unstructured":"Xu F, Schillinger JA, Sternberg MR, Johnson RE, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988\u20131994. J Infect Dis. 2002;185(8):1019\u201324. https:\/\/doi.org\/10.1086\/340041.","journal-title":"J Infect Dis"},{"key":"9684_CR5","unstructured":"Fauquet CM, Mayo MA, Maniloff J, Desselberger U. Family Herpesviridae. In: Virus taxonomy: Eighth report of the International Committee on Taxonomy of Viruses. London: Academic Press; 2005. p. 193\u2013212."},{"key":"9684_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4684-7012-3","volume-title":"The Herpesviruses","author":"B Roizman","year":"1982","unstructured":"Roizman B. The family Herpesviridae: general description, taxonomy, and classification. In: Roizman B, editor. The Herpesviruses, vol. 1. New York: Plenum Press; 1982. p. 1\u201323. https:\/\/doi.org\/10.1007\/978-1-4684-7012-3."},{"issue":"3\u20134","key":"9684_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.vetmic.2005.11.006","volume":"113","author":"M Ackermann","year":"2006","unstructured":"Ackermann M. Pathogenesis of gammaherpesvirus infections. Vet Microbiol. 2006;113(3\u20134):211\u201322. https:\/\/doi.org\/10.1016\/j.vetmic.2005.11.006.","journal-title":"Vet Microbiol"},{"issue":"1","key":"9684_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrmicro796","volume":"2","author":"B Damania","year":"2004","unstructured":"Damania B. Oncogenic \u03b3-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol. 2004;2(1):34\u201346. https:\/\/doi.org\/10.1038\/nrmicro796.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"9684_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/pathogens5010018","volume":"5","author":"HC Jha","year":"2016","unstructured":"Jha HC, Banerjee S, Robertson ES. The role of gammaherpesviruses in c\u00e2ncer pathogenesis. Pathogens. 2016;5(1):18. https:\/\/doi.org\/10.3390\/pathogens5010018.","journal-title":"Pathogens"},{"issue":"13","key":"9684_CR10","doi-asserted-by":"publisher","first-page":"7696","DOI":"10.1128\/JVI.77.13.7696-7701.2003","volume":"77","author":"SA Tibbetts","year":"2003","unstructured":"Tibbetts SA, Loh J, van Berkel V, McClellan JS, et al. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol. 2003;77(13):7696\u2013701. https:\/\/doi.org\/10.1128\/JVI.77.13.7696-7701.2003.","journal-title":"J Virol"},{"issue":"19","key":"9684_CR11","doi-asserted-by":"publisher","first-page":"10485","DOI":"10.1128\/JVI.78.19.10485-10493.2004","volume":"78","author":"JP Stewart","year":"2004","unstructured":"Stewart JP, Silvia OJ, Atkin IMD, Hughes DJ, Ebrahimi B, Adler H. In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis. J Virol. 2004;78(19):10485\u201393. https:\/\/doi.org\/10.1128\/JVI.78.19.10485-10493.2004.","journal-title":"J Virol"},{"issue":"1408","key":"9684_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1098\/rstb.2000.0780","volume":"356","author":"H Fickenscher","year":"2001","unstructured":"Fickenscher H, Fleckenstein B. Herpesvirus saimiri. Philos Trans R Soc Lond B Biol Sci. 2001;356(1408):545\u201367. https:\/\/doi.org\/10.1098\/rstb.2000.0780.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"11","key":"9684_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1590\/S0100-879X2004001100009","volume":"37","author":"LF Lopes","year":"2004","unstructured":"Lopes LF, Bacchi MM, Elgui-de-Oliveira D, Zanati SG, Alvarenga M, Bacchi CE. Epstein-Barr virus infection and gastric carcinoma in S\u00e3o Paulo state. Brazil Braz J Med Biol Res. 2004;37(11):1707\u201312. https:\/\/doi.org\/10.1590\/S0100-879X2004001100009.","journal-title":"Brazil Braz J Med Biol Res"},{"issue":"1","key":"9684_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-8-7","volume":"8","author":"K Alibek","year":"2013","unstructured":"Alibek K, Kakpenova A, Baiken Y. Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agents Cancer. 2013;8(1):7. https:\/\/doi.org\/10.1186\/1750-9378-8-7.","journal-title":"Infect Agents Cancer"},{"issue":"4","key":"9684_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1081\/CNV-200026386","volume":"22","author":"E Ozyar","year":"2004","unstructured":"Ozyar E, Ayhan A, Korcum AF, Atahan IL. Prognostic role of Epstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma. Cancer Invest. 2004;22(4):483\u201391. https:\/\/doi.org\/10.1081\/CNV-200026386.","journal-title":"Cancer Invest"},{"issue":"5","key":"9684_CR16","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/s41418-019-0435-1","volume":"27","author":"L Fitzsimmons","year":"2020","unstructured":"Fitzsimmons L, Cartlidge R, Chang C, et al. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. Cell Death Differ. 2020;27(5):1554\u201368. https:\/\/doi.org\/10.1038\/s41418-019-0435-1.","journal-title":"Cell Death Differ"},{"issue":"5","key":"9684_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hiv.12584","volume":"19","author":"Z Liu","year":"2018","unstructured":"Liu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The worldwide incidence of Kaposi\u2019s sarcoma in the HIV\/AIDS era. HIV Med. 2018;19(5):355\u201364. https:\/\/doi.org\/10.1111\/hiv.12584.","journal-title":"HIV Med"},{"key":"9684_CR18","unstructured":"American Society of Clinical Oncology. Cancer.Net \u2013 Doctor-Approved Patient Information. https:\/\/www.cancer.net\/. Accessed February 20, 2022."},{"issue":"8794","key":"9684_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0140-6736(92)90793-3","volume":"339","author":"V Beral","year":"1992","unstructured":"Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, et al. Risk of Kaposi\u2019s sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet. 1992;339(8794):555\u20139. https:\/\/doi.org\/10.1016\/0140-6736(92)90793-3.","journal-title":"Lancet"},{"issue":"5192","key":"9684_CR20","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma. Science. 1994;266(5192):1865\u20139. https:\/\/doi.org\/10.1126\/science.7997879.","journal-title":"Science"},{"issue":"1","key":"9684_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0190-9622(97)70295-8","volume":"37","author":"L Kem\u00e9ny","year":"1997","unstructured":"Kem\u00e9ny L, Gyulai R, Kiss M, et al. Kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus-8: a new virus in human pathology. J Am Acad Dermatol. 1997;37(1):139\u201342. https:\/\/doi.org\/10.1016\/S0190-9622(97)70295-8.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"9684_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm0396-342","volume":"2","author":"R Renne","year":"1996","unstructured":"Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, et al. Lytic growth of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996;2(3):342\u20136. https:\/\/doi.org\/10.1038\/nm0396-342.","journal-title":"Nat Med"},{"issue":"11","key":"9684_CR23","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1128\/JVI.70.11.8151-8154.1996","volume":"70","author":"R Renne","year":"1996","unstructured":"Renne R, Lagunoff M, Zhong W, Ganem D. The size and conformation of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol. 1996;70(11):8151\u20134. https:\/\/doi.org\/10.1128\/JVI.70.11.8151-8154.1996.","journal-title":"J Virol"},{"issue":"1","key":"9684_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-419X(02)00003-9","volume":"1602","author":"RG Jenner","year":"2002","unstructured":"Jenner RG, Boshoff C. The molecular pathology of Kaposi\u2019s sarcoma-associated herpesvirus. Biochim Biophys Acta. 2002;1602(1):1\u201322. https:\/\/doi.org\/10.1016\/S0304-419X(02)00003-9.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"9684_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1006\/viro.2000.0219","volume":"269","author":"H Katano","year":"2000","unstructured":"Katano H, Sato Y, Kurata T, Mori S, Sata T. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi\u2019s sarcoma, and multicentric Castleman\u2019s disease. Virology. 2000;269(2):335\u201344. https:\/\/doi.org\/10.1006\/viro.2000.0219.","journal-title":"Virology"},{"issue":"5","key":"9684_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"9684_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41467-020-20778-9","volume":"12","author":"TP Lippert","year":"2021","unstructured":"Lippert TP, Marzec P, Idilli AI, Sarek G, Vancevska A, Bower M, et al. Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres. Nat Commun. 2021;12:512. https:\/\/doi.org\/10.1038\/s41467-020-20778-9.","journal-title":"Nat Commun"},{"issue":"20","key":"9684_CR28","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.1128\/jvi.74.20.9646-9654.2000","volume":"74","author":"L Wu","year":"2000","unstructured":"Wu L, Lo P, Yu X, Stoops JK, Forghani B, Zhou ZH. Three-dimensional structure of the human herpesvirus 8 capsid. J Virol. 2000;74(20):9646\u201354. https:\/\/doi.org\/10.1128\/jvi.74.20.9646-9654.2000.","journal-title":"J Virol"},{"issue":"1","key":"9684_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1128\/JVI.70.1.549-558.1996","volume":"70","author":"PS Moore","year":"1996","unstructured":"Moore PS, Gao JS, Dominguez G, Cesarman E, Lungu O, Knowles M, et al. Primary characterization of a herpesvirus-like agent associated with Kaposi\u2019s sarcoma. J Virol. 1996;70(1):549\u201358. https:\/\/doi.org\/10.1128\/JVI.70.1.549-558.1996.","journal-title":"J Virol"},{"key":"9684_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/bs.aivir.2019.05.003","volume":"104","author":"BS Mohl","year":"2019","unstructured":"Mohl BS, Chen J, Longnecker R. Gammaherpesvirus entry and fusion: a tale how two human pathogenic viruses enter their host cells. Adv Virus Res. 2019;104:313\u201343. https:\/\/doi.org\/10.1016\/bs.aivir.2019.05.003.","journal-title":"Adv Virus Res"},{"issue":"12","key":"9684_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/v11121073","volume":"11","author":"JS Dollery","year":"2019","unstructured":"Dollery JS. Towards understanding KSHV fusion and entry. Viruses. 2019;11(12):1073. https:\/\/doi.org\/10.3390\/v11121073.","journal-title":"Viruses"},{"issue":"23","key":"9684_CR32","doi-asserted-by":"publisher","first-page":"11583","DOI":"10.1128\/JVI.75.23.11583-11593.2001","volume":"75","author":"A Birkmann","year":"2001","unstructured":"Birkmann A, Mahr K, Ensser A, Ya\u011fubo\u011flu S, Titgemeyer F, Fleckenstein B, et al. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol. 2001;75(23):11583\u201393. https:\/\/doi.org\/10.1128\/JVI.75.23.11583-11593.2001.","journal-title":"J Virol"},{"issue":"24","key":"9684_CR33","doi-asserted-by":"publisher","first-page":"15099","DOI":"10.1128\/JVI.79.24.15099-15106.2005","volume":"79","author":"JL Taylor","year":"2005","unstructured":"Taylor JL, Bennett HN, Snyder BA, Moore PS, Chang Y. Transcriptional analysis of latent and inducible Kaposi\u2019s sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol. 2005;79(24):15099\u2013106. https:\/\/doi.org\/10.1128\/JVI.79.24.15099-15106.2005.","journal-title":"J Virol"},{"key":"9684_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.604536","volume":"11","author":"W Liu","year":"2021","unstructured":"Liu W, Zhang Y, Luo B. Long non-coding RNAs in gammaherpesvirus infections: their roles in tumorigenic mechanisms. Front Microbiol. 2021;11:604536. https:\/\/doi.org\/10.3389\/fmicb.2020.604536.","journal-title":"Front Microbiol"},{"key":"9684_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.595318","volume":"11","author":"M Campbell","year":"2020","unstructured":"Campbell M, Yang WS, Yeh WW, Kao CH, Chang PC. Epigenetic regulation of Kaposi\u2019s sarcoma-associated herpesvirus latency. Front Microbiol. 2020;11:595318. https:\/\/doi.org\/10.3389\/fmicb.2020.595318.","journal-title":"Front Microbiol"},{"key":"9684_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1743-422X-2-78","volume":"2","author":"DC Edelman","year":"2005","unstructured":"Edelman DC. Human herpesvirus 8\u2014a novel human pathogen. Virol J. 2005;2:78. https:\/\/doi.org\/10.1186\/1743-422X-2-78.","journal-title":"Virol J"},{"issue":"18","key":"9684_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332(18):1186\u201391. https:\/\/doi.org\/10.1056\/NEJM199505043321802.","journal-title":"N Engl J Med"},{"issue":"10","key":"9684_CR38","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1128\/JVI.72.10.8309-8315.1998","volume":"72","author":"D Dittmer","year":"1998","unstructured":"Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. A cluster of latently expressed genes in Kaposi\u2019s sarcoma-associated herpesvirus. J Virol. 1998;72(10):8309\u201315. https:\/\/doi.org\/10.1128\/JVI.72.10.8309-8315.1998.","journal-title":"J Virol"},{"issue":"12","key":"9684_CR39","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1128\/JVI.75.12.5614-5626.2001","volume":"75","author":"DM Ciufo","year":"2001","unstructured":"Ciufo DM, Cannon JS, Poole LJ, Wu FY, Murray P, Ambinder RF, et al. Spindle cell conversion by Kaposi\u2019s sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol. 2001;75(12):5614\u201326. https:\/\/doi.org\/10.1128\/JVI.75.12.5614-5626.2001.","journal-title":"J Virol"},{"issue":"3","key":"9684_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.coviro.2013.04.003","volume":"3","author":"HS Chen","year":"2013","unstructured":"Chen HS, Lu F, Lieberman PM. Epigenetic regulation of EBV and KSHV latency. Curr Opin Virol. 2013;3(3):251\u20139. https:\/\/doi.org\/10.1016\/j.coviro.2013.04.003.","journal-title":"Curr Opin Virol"},{"issue":"9","key":"9684_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007267","volume":"14","author":"SE Hopcraft","year":"2018","unstructured":"Hopcraft SE, Pattenden SG, James LI, Frye S, Dittmer DP, Damania B. Chromatin remodeling controls Kaposi\u2019s sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog. 2018;14(9):e1007267. https:\/\/doi.org\/10.1371\/journal.ppat.1007267.","journal-title":"PLoS Pathog"},{"issue":"3","key":"9684_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nm0397-287","volume":"3","author":"J Nicholas","year":"1997","unstructured":"Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, et al. Kaposi\u2019s sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med. 1997;3(3):287\u201392. https:\/\/doi.org\/10.1038\/nm0397-287.","journal-title":"Nat Med"},{"issue":"15","key":"9684_CR43","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","volume":"77","author":"HJ Brown","year":"2003","unstructured":"Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R. NF-\u03bab inhibits gammaherpesvirus lytic replication. J Virol. 2003;77(15):8532\u201340. https:\/\/doi.org\/10.1128\/JVI.77.15.8532-8540.2003.","journal-title":"J Virol"},{"issue":"21","key":"9684_CR44","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1128\/JVI.01349-08","volume":"82","author":"W Bu","year":"2008","unstructured":"Bu W, Palmeri D, Krishnan R, et al. Identification of direct transcriptional targets of the Kaposi\u2019s sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. J Virol. 2008;82(21):10709\u201323. https:\/\/doi.org\/10.1128\/JVI.01349-08.","journal-title":"J Virol"},{"issue":"12","key":"9684_CR45","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/v6124961","volume":"6","author":"T Uppal","year":"2014","unstructured":"Uppal T, Banerjee S, Sun Z, Verma SC, Robertson ES. KSHV LANA\u2014the master regulator of KSHV latency. Viruses. 2014;6(12):4961\u201398. https:\/\/doi.org\/10.3390\/v6124961.","journal-title":"Viruses"},{"issue":"22","key":"9684_CR46","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.1128\/JVI.76.22.11677-11687.2002","volume":"76","author":"J Hu","year":"2002","unstructured":"Hu J, Garber AC, Renne R. The latency-associated nuclear antigen of Kaposi\u2019s sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol. 2002;76(22):11677\u201387. https:\/\/doi.org\/10.1128\/JVI.76.22.11677-11687.2002.","journal-title":"J Virol"},{"key":"9684_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01149","volume":"7","author":"F Juillard","year":"2016","unstructured":"Juillard F, Tan M, Li S, Kaye KM. Kaposi\u2019s sarcoma herpesvirus genome persistence. Front Microbiol. 2016;7:1149. https:\/\/doi.org\/10.3389\/fmicb.2016.01149.","journal-title":"Front Microbiol"},{"key":"9684_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.604351","volume":"10","author":"E Ohsaki","year":"2020","unstructured":"Ohsaki E, Ueda K. Interplay between KSHV and the host DNA damage response. Front Cell Infect Microbiol. 2020;10:604351. https:\/\/doi.org\/10.3389\/fcimb.2020.604351.","journal-title":"Front Cell Infect Microbiol"},{"issue":"Pt 1","key":"9684_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1099\/0022-1317-80-1-83","volume":"80","author":"Y Yu","year":"1999","unstructured":"Yu Y, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK. Induction of human herpesvirus 8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol. 1999;80(Pt 1):83\u201390. https:\/\/doi.org\/10.1099\/0022-1317-80-1-83.","journal-title":"J Gen Virol"},{"issue":"1","key":"9684_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/viro.1999.0077","volume":"266","author":"J Chang","year":"2000","unstructured":"Chang J, Renne R, Dittmer D, Ganem D. Inflammatory cytokines and the reactivation of Kaposi\u2019s sarcoma-associated herpesvirus lytic replication. Virology. 2000;266(1):17\u201325. https:\/\/doi.org\/10.1006\/viro.1999.0077.","journal-title":"Virology"},{"issue":"1","key":"9684_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.virol.2007.09.016","volume":"371","author":"J Xie","year":"2008","unstructured":"Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ. Reactivation of Kaposi\u2019s sarcoma-associated herpesvirus from latency requires MEK\/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology. 2008;371(1):139\u201354. https:\/\/doi.org\/10.1016\/j.virol.2007.09.016.","journal-title":"Virology"},{"issue":"7","key":"9684_CR52","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1182\/blood.V86.7.2708.2708","volume":"86","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) DNA sequences. Blood. 1995;86(7):2708\u201314. https:\/\/doi.org\/10.1182\/blood.V86.7.2708.2708.","journal-title":"Blood"},{"issue":"7","key":"9684_CR53","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1182\/blood.V88.7.2648.2648","volume":"88","author":"L Arvanitakis","year":"1996","unstructured":"Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8) in the absence of Epstein-Barr virus. Blood. 1996;88(7):2648\u201354. https:\/\/doi.org\/10.1182\/blood.V88.7.2648.2648.","journal-title":"Blood"},{"issue":"12","key":"9684_CR54","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1182\/blood.V87.12.4937.4937","volume":"87","author":"W Said","year":"1996","unstructured":"Said W, Chien K, Takeuchi S, Tasaka T, Asou H, Cho SK, et al. Kaposi\u2019s sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood. 1996;87(12):4937\u201343. https:\/\/doi.org\/10.1182\/blood.V87.12.4937.4937.","journal-title":"Blood"},{"key":"9684_CR55","doi-asserted-by":"publisher","unstructured":"Friborg J Jr, Kong WP, Flowers CC, et al. Distinct biology of Kaposi\u2019s sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas. J Virol. 1998;72(12):10073\u201382. https:\/\/doi.org\/10.1128\/JVI.72.12.10073-10082.1998.","DOI":"10.1128\/JVI.72.12.10073-10082.1998"},{"issue":"10","key":"9684_CR56","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1128\/JVI.73.10.8268-8278.1999","volume":"73","author":"X Wan","year":"1999","unstructured":"Wan X, Wang H, Nicholas J. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol. 1999;73(10):8268\u201378. https:\/\/doi.org\/10.1128\/JVI.73.10.8268-8278.1999.","journal-title":"J Virol"},{"issue":"5293","key":"9684_CR57","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","volume":"274","author":"PS Moore","year":"1996","unstructured":"Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996;274(5293):1739\u201344. https:\/\/doi.org\/10.1126\/science.274.5293.1739.","journal-title":"Science"},{"issue":"3","key":"9684_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006256","volume":"13","author":"ZE Sychev","year":"2017","unstructured":"Sychev ZE, Hu A, DiMaio TA, Gitter A, Camp ND, Noble WS, et al. Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome-mediated lipid metabolism. PLoS Pathog. 2017;13(3):e1006256. https:\/\/doi.org\/10.1371\/journal.ppat.1006256.","journal-title":"PLoS Pathog"},{"issue":"22","key":"9684_CR59","doi-asserted-by":"publisher","first-page":"14457","DOI":"10.1128\/JVI.79.22.14457-14464.2005","volume":"79","author":"M Pearce","year":"2005","unstructured":"Pearce M, Matsumura S, Wilson AC. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi\u2019s sarcoma-associated herpesvirus originate from a common promoter. J Virol. 2005;79(22):14457\u201364. https:\/\/doi.org\/10.1128\/JVI.79.22.14457-14464.2005.","journal-title":"J Virol"},{"issue":"3","key":"9684_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1386-6532(00)00109-1","volume":"16","author":"S Muralidhar","year":"2000","unstructured":"Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Reitz M, Nicholas J. Characterization of the human herpesvirus 8 (Kaposi\u2019s sarcoma-associated herpesvirus) oncogene, Kaposin (ORF K12). J Clin Virol. 2000;16(3):203\u201313. https:\/\/doi.org\/10.1016\/S1386-6532(00)00109-1.","journal-title":"J Clin Virol"},{"issue":"1","key":"9684_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/v7010116","volume":"7","author":"P Purushothaman","year":"2015","unstructured":"Purushothaman P, Uppal T, Verma SC. Molecular biology of KSHV lytic reactivation. Viruses. 2015;7(1):116\u201353. https:\/\/doi.org\/10.3390\/v7010116.","journal-title":"Viruses"},{"issue":"4","key":"9684_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215394","volume":"14","author":"R Kaul","year":"2019","unstructured":"Kaul R, Purushothaman P, Uppal T, Verma SC. KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression. PLoS ONE. 2019;14(4):e0215394. https:\/\/doi.org\/10.1371\/journal.pone.0215394.","journal-title":"PLoS ONE"},{"issue":"7","key":"9684_CR63","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1128\/JVI.78.7.3601-3620.2004","volume":"78","author":"HH Krishnan","year":"2004","unstructured":"Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi\u2019s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol. 2004;78(7):3601\u201320. https:\/\/doi.org\/10.1128\/JVI.78.7.3601-3620.2004.","journal-title":"J Virol"},{"issue":"2","key":"9684_CR64","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1128\/JVI.75.2.891-902.2001","volume":"75","author":"RG Jenner","year":"2001","unstructured":"Jenner RG, Alba MM, Boshoff C, Kellam P. Kaposi\u2019s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol. 2001;75(2):891\u2013902. https:\/\/doi.org\/10.1128\/JVI.75.2.891-902.2001.","journal-title":"J Virol"},{"issue":"6","key":"9684_CR65","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1128\/JVI.79.6.3479-3487.2005","volume":"79","author":"Y Xu","year":"2005","unstructured":"Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ, Pari GS. A kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J Virol. 2005;79(6):3479\u201387. https:\/\/doi.org\/10.1128\/JVI.79.6.3479-3487.2005.","journal-title":"J Virol"},{"issue":"24","key":"9684_CR66","doi-asserted-by":"publisher","first-page":"e01034","DOI":"10.1128\/JVI.01034-18","volume":"92","author":"DJ Weed","year":"2018","unstructured":"Weed DJ, Dollery SJ, Komala Sari T, Nicola AV. Acidic pH mediates changes in antigenic and oligomeric conformation of herpes simplex virus gB and is a determinant of cell-specific entry. J Virol. 2018;92(24):e01034-e1118. https:\/\/doi.org\/10.1128\/JVI.01034-18.","journal-title":"J Virol"},{"issue":"3","key":"9684_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1590\/S0001-37652009000300007","volume":"81","author":"JL Dreyfuss","year":"2009","unstructured":"Dreyfuss JL, Regatieri CV, Jarrouge TR, Cavalheiro RP, Sampaio LO, Nader HB. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. An Acad Bras Cienc. 2009;81(3):409\u201329. https:\/\/doi.org\/10.1590\/S0001-37652009000300007.","journal-title":"An Acad Bras Cienc"},{"issue":"2","key":"9684_CR68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/viro.2000.0851","volume":"282","author":"SM Akula","year":"2001","unstructured":"Akula SM, Wang FZ, Vieira J, Chandran B. Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology. 2001;282(2):245\u201355. https:\/\/doi.org\/10.1006\/viro.2000.0851.","journal-title":"Virology"},{"issue":"2","key":"9684_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/viro.2001.0921","volume":"284","author":"SM Akula","year":"2001","unstructured":"Akula SM, Pramod NP, Wang FZ, Chandran B. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology. 2001;284(2):235\u201349. https:\/\/doi.org\/10.1006\/viro.2001.0921.","journal-title":"Virology"},{"issue":"9","key":"9684_CR70","doi-asserted-by":"publisher","first-page":"876","DOI":"10.4161\/cbt.3.9.1054","volume":"3","author":"PW Ford","year":"2004","unstructured":"Ford PW, Hamden KE, Whitman AG, McCubrey JA, Akula SM. Vascular endothelial growth factor augments human herpesvirus-8 (HHV-8\/KSHV) infection. Cancer Biol Ther. 2004;3(9):876\u201381. https:\/\/doi.org\/10.4161\/cbt.3.9.1054.","journal-title":"Cancer Biol Ther"},{"key":"9684_CR71","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0092-8674(02)00628-1","volume":"108","author":"SM Akula","year":"2002","unstructured":"Akula SM, Pramod NP, Wang FZ, Chandran B. Integrin \u03b13\u03b21 (CD49c\/29) is a cellular receptor for Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8) entry into target cells. Cell. 2002;108:407\u201319. https:\/\/doi.org\/10.1016\/s0092-8674(02)00628-1.","journal-title":"Cell"},{"issue":"24","key":"9684_CR72","doi-asserted-by":"publisher","first-page":"12126","DOI":"10.1128\/JVI.01146-08","volume":"82","author":"MV Veettil","year":"2008","unstructured":"Veettil MV, Sadagopan S, Sharma-Walia N, Wang FZ, Raghu H, Varga L, et al. Kaposi\u2019s sarcoma-associated herpesvirus forms a multimolecular complex of integrins (\u03b1V\u03b25, \u03b1V\u03b23, and \u03b13\u03b21) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J Virol. 2008;82(24):12126\u201344. https:\/\/doi.org\/10.1128\/JVI.01146-08.","journal-title":"J Virol"},{"issue":"4","key":"9684_CR73","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1038\/ncb0402-e69","volume":"4","author":"G Nemerow","year":"2002","unstructured":"Nemerow G, Cheresh D. Herpesvirus hijacks an integrin. Nat Cell Biol. 2002;4(4):E69\u201371. https:\/\/doi.org\/10.1038\/ncb0402-e69.","journal-title":"Nat Cell Biol"},{"issue":"5769","key":"9684_CR74","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1126\/science.1120878","volume":"311","author":"JA Kaleeba","year":"2006","unstructured":"Kaleeba JA, Berger EA. Kaposi\u2019s sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science. 2006;311(5769):1921\u20134. https:\/\/doi.org\/10.1126\/science.1120878.","journal-title":"Science"},{"issue":"8","key":"9684_CR75","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tim.2017.02.002","volume":"25","author":"J Qin","year":"2017","unstructured":"Qin J, Li W, Gao SJ, Lu C. KSHV microRNAs: tricks of the devil. Trends Microbiol. 2017;25(8):648\u201361. https:\/\/doi.org\/10.1016\/j.tim.2017.02.002.","journal-title":"Trends Microbiol"},{"issue":"4","key":"9684_CR76","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1042\/BSR20090163","volume":"30","author":"Y Zeng","year":"2010","unstructured":"Zeng Y, Li Y, Chen RS, He X, Yang L, Li W. Overexpression of xCT induces up-regulation of 14\u20133-3\u03b2 in Kaposi\u2019s sarcoma. Biosci Rep. 2010;30(4):277\u201383. https:\/\/doi.org\/10.1042\/BSR20090163.","journal-title":"Biosci Rep"},{"issue":"3","key":"9684_CR77","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.176.3.1741","volume":"176","author":"G Rappocciolo","year":"2006","unstructured":"Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, Borowski L, et al. DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol. 2006;176(3):1741\u20139. https:\/\/doi.org\/10.4049\/jimmunol.176.3.1741.","journal-title":"J Immunol"},{"issue":"9","key":"9684_CR78","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/JVI.01587-07","volume":"82","author":"G Rappocciolo","year":"2008","unstructured":"Rappocciolo G, Hensler HR, Jais M, Reinhart TA, Pegu A, Jenkins FJ, et al. Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J Virol. 2008;82(9):4793\u2013806. https:\/\/doi.org\/10.1128\/JVI.01587-07.","journal-title":"J Virol"},{"key":"9684_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.virusres.2014.07.003","volume":"190","author":"HR Hensler","year":"2014","unstructured":"Hensler HR, Tomaszewski MJ, Rappocciolo G, Rinaldo CR, Jenkins FJ. Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN. Virus Res. 2014;190:97\u2013103. https:\/\/doi.org\/10.1016\/j.virusres.2014.07.003.","journal-title":"Virus Res"},{"issue":"1","key":"9684_CR80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2010.07.012","volume":"406","author":"N Kerur","year":"2010","unstructured":"Kerur N, Veettil MV, Sharma-Walia N, Sadagopan S, Bottero V, Paul AG, et al. Characterization of entry and infection of monocytic THP-1 cells by Kaposi\u2019s sarcoma-associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling. Virology. 2010;406(1):103\u201316. https:\/\/doi.org\/10.1016\/j.virol.2010.07.012.","journal-title":"Virology"},{"issue":"7","key":"9684_CR81","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nm.2805","volume":"18","author":"AS Hahn","year":"2012","unstructured":"Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, et al. The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi\u2019s sarcoma-associated herpesvirus. Nat Med. 2012;18(7):961\u20136. https:\/\/doi.org\/10.1038\/nm.2805.","journal-title":"Nat Med"},{"issue":"20","key":"9684_CR82","doi-asserted-by":"publisher","first-page":"e00909","DOI":"10.1128\/JVI.00909-17","volume":"91","author":"G Rappocciolo","year":"2017","unstructured":"Rappocciolo G, Jais M, Piazza PA, DeLucia DC, Jenkins FJ, Rinaldo CR. Human herpesvirus 8 infects and replicates in Langerhans cells and interstitial dermal dendritic cells and impairs their function. J Virol. 2017;91(20):e00909-e917. https:\/\/doi.org\/10.1128\/JVI.00909-17.","journal-title":"J Virol"},{"key":"9684_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00054","volume":"7","author":"P Purushothaman","year":"2016","unstructured":"Purushothaman P, Dabral P, Gupta N, Sarkar R, Verma SC. KSHV genome replication and maintenance. Front Microbiol. 2016;7:54. https:\/\/doi.org\/10.3389\/fmicb.2016.00054.","journal-title":"Front Microbiol"},{"key":"9684_CR84","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.284.5414.641","volume":"284","author":"ME Ballestas","year":"1999","unstructured":"Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999;284:641\u20134. https:\/\/doi.org\/10.1126\/science.284.5414.641.","journal-title":"Science"},{"key":"9684_CR85","doi-asserted-by":"publisher","unstructured":"Friborg J Jr, Kong W, Hottiger MO, Nabel GJ. P53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 1999;402:889\u201394. https:\/\/doi.org\/10.1038\/47266.","DOI":"10.1038\/47266"},{"issue":"10","key":"9684_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020116","volume":"2","author":"Q-L Cai","year":"2006","unstructured":"Cai Q-L, Knight JS, Verma SC, Zald P, Robertson ES. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2006;2(10):e116. https:\/\/doi.org\/10.1371\/journal.ppat.0020116.","journal-title":"PLoS Pathog"},{"issue":"19","key":"9684_CR87","doi-asserted-by":"publisher","first-page":"10375","DOI":"10.1128\/JVI.00226-11","volume":"85","author":"KR Alkharsah","year":"2011","unstructured":"Alkharsah KR, Singh VV, Bosco R, Santag S, Grundhoff A, Konrad A, et al. Deletion of Kaposi\u2019s sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J Virol. 2011;85(19):10375\u201388. https:\/\/doi.org\/10.1128\/JVI.00226-11.","journal-title":"J Virol"},{"issue":"2","key":"9684_CR88","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1128\/JVI.00629-08","volume":"83","author":"M Thurau","year":"2009","unstructured":"Thurau M, Marquardt G, Gonin-Laurent N, et al. Viral inhibitor of apoptosis vFLIP\/K13 protects endothelial cells against superoxide-induced cell death. J Virol. 2009;83(2):598\u2013611. https:\/\/doi.org\/10.1128\/JVI.00629-08.","journal-title":"J Virol"},{"key":"9684_CR89","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/cdd.2017.7","volume":"17","author":"C Quintavalle","year":"2017","unstructured":"Quintavalle C, Incoronato M, Puca L, et al. Correction: c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3\u03b2 activity. Cell Death Differ. 2017;17:1908\u201316. https:\/\/doi.org\/10.1038\/cdd.2017.7.","journal-title":"Cell Death Differ"},{"issue":"2","key":"9684_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020358","volume":"12","author":"A Gallo","year":"2020","unstructured":"Gallo A, Miceli V, Bulati M, Iannolo G, Contino F, Conaldi PG. Viral miRNAs as active players and participants in tumorigenesis. Cancers (Basel). 2020;12(2):358. https:\/\/doi.org\/10.3390\/cancers12020358.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"9684_CR91","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.chom.2009.11.008","volume":"6","author":"P Bellare","year":"2009","unstructured":"Bellare P, Ganem D. Regulation of KSHV lytic switch protein expression by a virus-encoded microrna: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe. 2009;6(6):570\u20135. https:\/\/doi.org\/10.1016\/j.chom.2009.11.008.","journal-title":"Cell Host Microbe"},{"key":"9684_CR92","doi-asserted-by":"publisher","first-page":"e1000389","DOI":"10.1371\/journal.ppat.1000389","volume":"5","author":"AJ O\u2019Hara","year":"2009","unstructured":"O\u2019Hara AJ, Chugh P, Wang L, et al. Pre-microRNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog. 2009;5:e1000389. https:\/\/doi.org\/10.1371\/journal.ppat.1000389.","journal-title":"PLoS Pathog"},{"key":"9684_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-013-9678-1","volume":"20","author":"AM Catrina","year":"2014","unstructured":"Catrina AM, Borze I, Guled M, et al. MicroRNA expression profiles in Kaposi\u2019s sarcoma. Pathol Oncol Res. 2014;20:10.1007\/s12253-013-9678-1. https:\/\/doi.org\/10.1007\/s12253-013-9678-1.","journal-title":"Pathol Oncol Res"},{"key":"9684_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.687629","volume":"11","author":"J Naipauer","year":"2021","unstructured":"Naipauer J, Sol\u00e1 MEG, Salyakina D, et al. A non-coding RNA network involved in KSHV tumorigenesis. Front Oncol. 2021;11:687629. https:\/\/doi.org\/10.3389\/fonc.2021.687629.","journal-title":"Front Oncol"},{"key":"9684_CR95","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1128\/JVI.06245-11","volume":"86","author":"Y Liu","year":"2012","unstructured":"Liu Y, Sun R, Lin X, Liang D, Deng Q, Lan K. Kaposi\u2019s sarcoma-associated herpesvirus-encoded microrna miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J Virol. 2012;86:1372\u201381. https:\/\/doi.org\/10.1128\/JVI.06245-11.","journal-title":"J Virol"},{"issue":"5","key":"9684_CR96","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1371\/journal.ppat.0030065","volume":"3","author":"MA Samols","year":"2007","unstructured":"Samols MA, Skalsky RL, Maldonado AM, Riva A, et al. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 2007;3(5):e65. https:\/\/doi.org\/10.1371\/journal.ppat.0030065.","journal-title":"PLoS Pathog"},{"key":"9684_CR97","doi-asserted-by":"publisher","first-page":"12836","DOI":"10.1128\/JVI.01804-07","volume":"81","author":"RL Skalsky","year":"2007","unstructured":"Skalsky RL, Samols MA, Plaisance KB, et al. Kaposi\u2019s sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol. 2007;81:12836\u201345. https:\/\/doi.org\/10.1128\/JVI.01804-07.","journal-title":"J Virol"},{"issue":"8","key":"9684_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005255","volume":"11","author":"HS Choi","year":"2015","unstructured":"Choi HS, Jain V, Krueger B, Marshall V, et al. Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) induces the oncogenic miR-17-92 cluster and down-regulates TGF-\u03b2 signaling. PLoS Pathog. 2015;11(8):e1005255. https:\/\/doi.org\/10.1371\/journal.ppat.1005255.","journal-title":"PLoS Pathog"},{"key":"9684_CR99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2017.04.018","volume":"20","author":"E Fuentes-Mattei","year":"2017","unstructured":"Fuentes-Mattei E, Giza DE, Shimizu M, et al. Plasma viral miRNAs indicate a high prevalence of occult viral infections. EBioMedicine. 2017;20:182\u201392. https:\/\/doi.org\/10.1016\/j.ebiom.2017.04.018.","journal-title":"EBioMedicine"},{"key":"9684_CR100","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.93.13.6641","volume":"93","author":"W Zhong","year":"1996","unstructured":"Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A. 1996;93:6641\u20136. https:\/\/doi.org\/10.1073\/pnas.93.13.6641.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9684_CR101","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1128\/JVI.72.6.4980-4988.1998","volume":"72","author":"S Muralidhar","year":"1998","unstructured":"Muralidhar S, Pumfery AM, Hassani M, et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi\u2019s sarcoma-associated herpesvirus) transforming gene. J Virol. 1998;72(6):4980\u20138. https:\/\/doi.org\/10.1128\/JVI.72.6.4980-4988.1998.","journal-title":"J Virol"},{"issue":"1","key":"9684_CR102","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/(sici)1097-0215(19970703)72:1<68::aid-ijc10>3.0.co;2-6","volume":"72","author":"M St\u00fcrzl","year":"1997","unstructured":"St\u00fcrzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi\u2019s sarcoma. Int J Cancer. 1997;72(1):68\u201371. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970703)72:1%3c68::aid-ijc10%3e3.0.co;2-6.","journal-title":"Int J Cancer"},{"issue":"7","key":"9684_CR103","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1128\/JVI.73.7.5722-5730.1999","volume":"73","author":"R Sadler","year":"1999","unstructured":"Sadler R, Wu L, Forghani B, et al. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi\u2019s sarcoma-associated herpesvirus. J Virol. 1999;73(7):5722\u201330. https:\/\/doi.org\/10.1128\/JVI.73.7.5722-5730.1999.","journal-title":"J Virol"},{"issue":"3","key":"9684_CR104","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1128\/JVI.71.3.1984-1991.1997","volume":"71","author":"M Li","year":"1997","unstructured":"Li M, Lee H, Yoon DW, et al. Kaposi\u2019s sarcoma-associated herpesvirus encodes a functional cyclin. J Virol. 1997;71(3):1984\u201391. https:\/\/doi.org\/10.1128\/JVI.71.3.1984-1991.1997.","journal-title":"J Virol"},{"key":"9684_CR105","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1128\/JVI.71.6.4193-4198.1997","volume":"71","author":"D Godden-Kent","year":"1997","unstructured":"Godden-Kent D, Talbot SJ, Boshoff C, et al. The cyclin encoded by Kaposi\u2019s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol. 1997;71:4193\u20138. https:\/\/doi.org\/10.1128\/JVI.71.6.4193-4198.1997.","journal-title":"J Virol"},{"key":"9684_CR106","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1099\/vir.0.79812-0","volume":"85","author":"EW Verschuren","year":"2004","unstructured":"Verschuren EW, Jones N, Evan GI. The cell cycle and how it is steered by Kaposi\u2019s sarcoma-associated herpesvirus cyclin. J Gen Virol. 2004;85:1347\u201361. https:\/\/doi.org\/10.1099\/vir.0.79812-0.","journal-title":"J Gen Virol"},{"issue":"2","key":"9684_CR107","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1006\/viro.2002.1561","volume":"299","author":"A Saveliev","year":"2002","unstructured":"Saveliev A, Zhu F, Yuan Y. Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi\u2019s sarcoma-associated herpesvirus. Virology. 2002;299(2):301\u201314. https:\/\/doi.org\/10.1006\/viro.2002.1561.","journal-title":"Virology"},{"issue":"7","key":"9684_CR108","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1128\/JVI.73.7.5556-5567.1999","volume":"73","author":"FX Zhu","year":"1999","unstructured":"Zhu FX, Cusano T, Yuan Y. Identification of the immediate-early transcripts of Kaposi\u2019s sarcoma-associated herpesvirus. J Virol. 1999;73(7):5556\u201367. https:\/\/doi.org\/10.1128\/JVI.73.7.5556-5567.1999.","journal-title":"J Virol"},{"issue":"24","key":"9684_CR109","doi-asserted-by":"publisher","first-page":"13637","DOI":"10.1128\/JVI.78.24.13637-13652.2004","volume":"78","author":"M Lu","year":"2004","unstructured":"Lu M, Suen J, Frias C, et al. Dissection of the Kaposi\u2019s sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir. J Virol. 2004;78(24):13637\u201352. https:\/\/doi.org\/10.1128\/JVI.78.24.13637-13652.2004.","journal-title":"J Virol"},{"key":"9684_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003847","volume":"10","author":"C Arias","year":"2014","unstructured":"Arias C, Weisburd B, Stern-Ginossar N, et al. KSHV 2.0: a comprehensive annotation of the Kaposi\u2019s sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog. 2014;10:e1003847. https:\/\/doi.org\/10.1371\/journal.ppat.1003847.","journal-title":"PLoS Pathog"},{"issue":"24","key":"9684_CR111","doi-asserted-by":"publisher","first-page":"e01532","DOI":"10.1128\/JVI.01532-17","volume":"91","author":"HJ Garrigues","year":"2017","unstructured":"Garrigues HJ, Howard K, Barcy S, et al. Full-length isoforms of Kaposi\u2019s sarcoma-associated herpesvirus latency-associated nuclear antigen accumulate in the cytoplasm of cells undergoing the lytic cycle of replication. J Virol. 2017;91(24):e01532-e1617. https:\/\/doi.org\/10.1128\/JVI.01532-17.","journal-title":"J Virol"},{"key":"9684_CR112","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1128\/JVI.77.12.6761-6768.2003","volume":"77","author":"M Haque","year":"2003","unstructured":"Haque M, Davis DA, Wang V, Widmer I, Yarchoan R. Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J Virol. 2003;77:6761\u20138. https:\/\/doi.org\/10.1128\/JVI.77.12.6761-6768.2003.","journal-title":"J Virol"},{"key":"9684_CR113","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1073\/pnas.051004198","volume":"98","author":"J Chen","year":"2001","unstructured":"Chen J, Ueda K, Sakakibara S, et al. Activation of latent Kaposi\u2019s sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci U S A. 2001;98:4119\u201324. https:\/\/doi.org\/10.1073\/pnas.051004198.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9684_CR114","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fmicb.2016.00334","volume":"7","author":"F Wei","year":"2016","unstructured":"Wei F, Gan J, Wang C, Zhu H, Zhao L, Lu H. Cell cycle regulatory functions of the KSHV oncoprotein LANA. Front Microbiol. 2016;7:334. https:\/\/doi.org\/10.3389\/fmicb.2016.00334.","journal-title":"Front Microbiol"},{"issue":"6","key":"9684_CR115","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1128\/JVI.01319-07","volume":"82","author":"Y Wang","year":"2008","unstructured":"Wang Y, Li H, Tang Q, Maul GG, Yuan Y. Kaposi\u2019s sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J Virol. 2008;82(6):2867\u201382. https:\/\/doi.org\/10.1128\/JVI.01319-07.","journal-title":"J Virol"},{"key":"9684_CR116","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fmicb.2017.00613","volume":"8","author":"KK Aneja","year":"2017","unstructured":"Aneja KK, Yuan Y. Reactivation and lytic replication of Kaposi\u2019s sarcoma-associated herpesvirus: an update. Front Microbiol. 2017;8:613. https:\/\/doi.org\/10.3389\/fmicb.2017.00613.","journal-title":"Front Microbiol"},{"issue":"5","key":"9684_CR117","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1128\/JVI.78.5.2609-2614.2004","volume":"78","author":"S Tang","year":"2004","unstructured":"Tang S, Yamanegi K, Zheng ZM. Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi\u2019s sarcoma-associated herpesvirus K8.1 late promoter. J Virol. 2004;78(5):2609\u201314. https:\/\/doi.org\/10.1128\/JVI.78.5.2609-2614.2004.","journal-title":"J Virol"},{"issue":"14","key":"9684_CR118","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1056\/NEJM199804023381403","volume":"338","author":"JN Martin","year":"1998","unstructured":"Martin JN, Ganem DE, Osmond DH, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338(14):948\u201354. https:\/\/doi.org\/10.1056\/NEJM199804023381403.","journal-title":"N Engl J Med"},{"issue":"10","key":"9684_CR119","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1086\/598684","volume":"199","author":"S Sanjos\u00e9","year":"2009","unstructured":"Sanjos\u00e9 S, Mbisa G, Alvarez SP, Benavente Y, Sukvirach S, Hieu NT, et al. Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis. 2009;199(10):1449\u201356. https:\/\/doi.org\/10.1086\/598684.","journal-title":"J Infect Dis"},{"issue":"5","key":"9684_CR120","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1086\/315482","volume":"181","author":"RJ Biggar","year":"2000","unstructured":"Biggar RJ, Whitby D, Marshall V, Linhares AC, Black FL. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis. 2000;181(5):1562\u20138. https:\/\/doi.org\/10.1086\/315482.","journal-title":"J Infect Dis"},{"issue":"9235","key":"9684_CR121","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0140-6736(00)02729-X","volume":"356","author":"S Plancoulaine","year":"2000","unstructured":"Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 2000;356(9235):1062\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(00)02729-X.","journal-title":"Lancet"},{"issue":"1","key":"9684_CR122","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1600-0714.2010.00959.x","volume":"40","author":"TRT Fran\u00e7a","year":"2011","unstructured":"Fran\u00e7a TRT, Ara\u00fajo RA, Ribeiro CM, Le\u00e3o JC. Salivary shedding of HHV-8 in people infected or not by human immunodeficiency virus 1. J Oral Pathol Med. 2011;40(1):97\u2013102. https:\/\/doi.org\/10.1111\/j.1600-0714.2010.00959.x.","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"9684_CR123","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1086\/424489","volume":"190","author":"SM Mbulaiteye","year":"2004","unstructured":"Mbulaiteye SM, Pfeiffer RM, Engels EA, Marshall V, Bakaki PM, Owor AM, et al. Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis. 2004;190(8):1382\u20136. https:\/\/doi.org\/10.1086\/424489.","journal-title":"J Infect Dis"},{"key":"9684_CR124","doi-asserted-by":"publisher","first-page":"9358947","DOI":"10.1155\/2020\/9358947","volume":"2020","author":"R Derafshi","year":"2020","unstructured":"Derafshi R, Ghapanchi J, Rezazadeh F, Kalantari MH, Naeeni AM, Farzin M, et al. PCR detection of HHV-8 DNA in the saliva of removable denture wearers compared to dentate cases in Shiraz, south of Iran. Biomed Res Int. 2020;2020:9358947. https:\/\/doi.org\/10.1155\/2020\/9358947.","journal-title":"Biomed Res Int"},{"issue":"1\u20132","key":"9684_CR125","first-page":"123","volume":"44","author":"M Coluzzi","year":"2002","unstructured":"Coluzzi M, Manno D, Guzzinati S, Tognazzo S, Zambon P, Arc\u00e0 B, et al. The bloodsucking arthropod bite as possible cofactor in the transmission of human herpesvirus-8 infection and in the expression of Kaposi\u2019s sarcoma disease. Parasitology. 2002;44(1\u20132):123\u20139.","journal-title":"Parassitologia"},{"issue":"11","key":"9684_CR126","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/sj.bjc.6601390","volume":"89","author":"JM Wojcicki","year":"2003","unstructured":"Wojcicki JM. Traditional behavioural practices, the exchange of saliva and HHV-8 transmission in sub-Saharan African populations. Br J Cancer. 2003;89(11):2016\u20137. https:\/\/doi.org\/10.1038\/sj.bjc.6601390.","journal-title":"Br J Cancer"},{"issue":"23","key":"9684_CR127","doi-asserted-by":"publisher","first-page":"8782","DOI":"10.1158\/0008-5472.CAN-04-2000","volume":"64","author":"S Plancoulaine","year":"2004","unstructured":"Plancoulaine S, Abel L, Tregouet D, Duprez R, van Beveren M, Tortevoye P, et al. Respective roles of serological status and blood specific anti-human herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res. 2004;64(23):8782\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2000.","journal-title":"Cancer Res"},{"key":"9684_CR128","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1172\/JCI43755","volume":"121","author":"J Myoung","year":"2011","unstructured":"Myoung J, Ganem D. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J Clin Invest. 2011;121:1130\u201340. https:\/\/doi.org\/10.1172\/JCI43755.","journal-title":"J Clin Invest"},{"issue":"13","key":"9684_CR129","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1056\/NEJMoa055009","volume":"355","author":"W Hladik","year":"2006","unstructured":"Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med. 2006;355(13):1331\u20138. https:\/\/doi.org\/10.1056\/NEJMoa055009.","journal-title":"N Engl J Med"},{"issue":"4","key":"9684_CR130","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.0041-1132.2005.04334.x","volume":"45","author":"SC Dollard","year":"2005","unstructured":"Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, et al. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion. 2005;45(4):500\u20133. https:\/\/doi.org\/10.1111\/j.0041-1132.2005.04334.x.","journal-title":"Transfusion"},{"issue":"2","key":"9684_CR131","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.bmt.1702113","volume":"25","author":"R Vescio","year":"2000","unstructured":"Vescio R, Wu C, Zheng L, et al. Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients. Bone Marrow Transplant. 2000;25(2):153\u201360. https:\/\/doi.org\/10.1038\/sj.bmt.1702113.","journal-title":"Bone Marrow Transplant"},{"issue":"5320","key":"9684_CR132","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1126\/science.276.5320.1851","volume":"276","author":"MB Rettig","year":"1997","unstructured":"Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, et al. Kaposi\u2019s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997;276(5320):1851\u20134. https:\/\/doi.org\/10.1126\/science.276.5320.1851.","journal-title":"Science"},{"issue":"6","key":"9684_CR133","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12250-017-4051-2","volume":"32","author":"Q Fang","year":"2017","unstructured":"Fang Q, Liu Z, Zhang Z, et al. Prevalence of Kaposi\u2019s sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis. Virol Sin. 2017;32(6):415\u201322. https:\/\/doi.org\/10.1007\/s12250-017-4051-2.","journal-title":"Virol Sin"},{"issue":"7","key":"9684_CR134","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/aid.1996.12.651","volume":"12","author":"M Corbellino","year":"1996","unstructured":"Corbellino M, Poirel L, Bestetti G, Pizzuto M, Aubin JT, Capra M, et al. Restricted tissue distribution of extralesional Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi\u2019s sarcoma. AIDS Res Hum Retroviruses. 1996;12(7):651\u20137. https:\/\/doi.org\/10.1089\/aid.1996.12.651.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"9684_CR135","doi-asserted-by":"publisher","first-page":"F15","DOI":"10.1097\/00002030-199702000-00001","volume":"11","author":"MR Howard","year":"1997","unstructured":"Howard MR, Whitby D, Bahadur G, Suggett F, Boshoff C, Tenant-Flowers M, et al. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS. 1997;11(7):F15\u20139. https:\/\/doi.org\/10.1097\/00002030-199702000-00001.","journal-title":"AIDS"},{"issue":"6\u20137","key":"9684_CR136","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10735-005-9010-9","volume":"36","author":"O Bagasra","year":"2005","unstructured":"Bagasra O, Patel D, Bobroski L, Abbasi JA, Bagasra AU, Baidouri H, et al. Localization of human herpesvirus type 8 in human sperms by in situ PCR. J Mol Histol. 2005;36(6\u20137):401\u201312. https:\/\/doi.org\/10.1007\/s10735-005-9010-9.","journal-title":"J Mol Histol"},{"issue":"2","key":"9684_CR137","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1128\/MMBR.65.2.208-231.2001","volume":"65","author":"N Dejucq","year":"2001","unstructured":"Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65(2):208\u201331. https:\/\/doi.org\/10.1128\/MMBR.65.2.208-231.2001.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"9684_CR138","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1158\/0008-5472.CAN-12-4196","volume":"183","author":"JG Mygatt","year":"2013","unstructured":"Mygatt JG, Singhal A, Sukumar G, Dalgard CL, Kaleeba JAR. Oncogenic herpesvirus HHV-8 promotes androgen-independent prostate cancer growth. Am J Pathol. 2013;183(5):1541\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4196.","journal-title":"Am J Pathol"},{"issue":"9","key":"9684_CR139","doi-asserted-by":"publisher","DOI":"10.5812\/ijcm.90667","volume":"12","author":"A Rakhshan","year":"2019","unstructured":"Rakhshan A, Moradi A, Ahadi M, Rezaei MS, Jamali E, Kazeminejad B, et al. The prevalence of human herpesvirus type 8 in semen specimens of HIV-negative Iranian population detected by nested PCR. Int J Cancer Manag. 2019;12(9):e90667. https:\/\/doi.org\/10.5812\/ijcm.90667.","journal-title":"Int J Cancer Manag"},{"issue":"1","key":"9684_CR140","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1086\/314563","volume":"179","author":"D Whitby","year":"1999","unstructured":"Whitby D, Smith NA, Matthews S, O\u2019Shea S, Sabin CA, Kulasegaram R, et al. Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis. 1999;179(1):234\u20136. https:\/\/doi.org\/10.1086\/314563.","journal-title":"J Infect Dis"},{"issue":"10","key":"9684_CR141","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/s0151-9638(05)79501-6","volume":"132","author":"C Becuwe","year":"2005","unstructured":"Becuwe C, Euvrard S, Bsshard S, et al. Kaposi\u2019s sarcoma and organ transplantation: 22 cases. Ann Dermatol Venereol. 2005;132(10):839\u201343. https:\/\/doi.org\/10.1016\/s0151-9638(05)79501-6.","journal-title":"Ann Dermatol Venereol"},{"key":"9684_CR142","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","volume":"339","author":"N Regamey","year":"1998","unstructured":"Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med. 1998;339:1358\u201363. https:\/\/doi.org\/10.1056\/NEJM199811053391903.","journal-title":"N Engl J Med"},{"key":"9684_CR143","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1128\/JCM.39.2.506-508.2001","volume":"39","author":"P Cattani","year":"2001","unstructured":"Cattani P, Capuano M, Graffeo R, Ricci R, Cerimele F, Cerimele D, et al. Kaposi\u2019s sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001;39:506\u20138. https:\/\/doi.org\/10.1128\/JCM.39.2.506-508.2001.","journal-title":"J Clin Microbiol"},{"key":"9684_CR144","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/ajt.16181","volume":"21","author":"SC Dollard","year":"2021","unstructured":"Dollard SC, et al. Donor-derived human herpesvirus 8 and development of Kaposi sarcoma among 6 recipients of organs from donors with high-risk sexual and substance use behavior. Am J Transplant. 2021;21:681\u20138. https:\/\/doi.org\/10.1111\/ajt.16181.","journal-title":"Am J Transplant"},{"issue":"1","key":"9684_CR145","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1086\/509621","volume":"195","author":"C Casper","year":"2007","unstructured":"Casper C, Krantz E, Selke S, Corey L, Wald A. Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J Infect Dis. 2007;195(1):30\u20136. https:\/\/doi.org\/10.1086\/509621.","journal-title":"J Infect Dis"},{"key":"9684_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0052-2","volume":"11","author":"RA Bender Ignacio","year":"2016","unstructured":"Bender Ignacio RA, Goldman JD, Magaret AS, et al. Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons. Infect Agents Cancer. 2016;11:7. https:\/\/doi.org\/10.1186\/s13027-016-0052-2.","journal-title":"Infect Agents Cancer"},{"key":"9684_CR147","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.immunol.25.022106.141634","volume":"25","author":"A Iwasaki","year":"2017","unstructured":"Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol. 2017;25:381\u2013418. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141634.","journal-title":"Annu Rev Immunol"},{"key":"9684_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00452","volume":"5","author":"DM Campbell","year":"2014","unstructured":"Campbell DM, Rappocciolo G, Jenkins FJ, Rinaldo CR. Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis. Front Microbiol. 2014;5:408.","journal-title":"Front Microbiol"},{"key":"9684_CR149","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1183\/09031936.00154212","volume":"42","author":"R Borie","year":"2013","unstructured":"Borie R, Cadranel J, Guihot A, Marcelin AG, Galicier L, Couderc LJ. Pulmonary manifestations of human herpesvirus-8 during HIV infection. Eur Respir J. 2013;42:1105\u201318. https:\/\/doi.org\/10.1183\/09031936.00154212.","journal-title":"Eur Respir J"},{"issue":"6","key":"9684_CR150","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/JVI.01532-10","volume":"85","author":"S Sadagopan","year":"2011","unstructured":"Sadagopan S, Veettil MV, Paudel N, Bottero V, Chandran B. Kaposi\u2019s sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. J Virol. 2011;85(6):2666\u201385. https:\/\/doi.org\/10.1128\/JVI.01532-10.","journal-title":"J Virol"},{"issue":"10","key":"9684_CR151","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/80459","volume":"6","author":"SA Radkov","year":"2000","unstructured":"Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi\u2019s sarcoma-associated herpesvirus targets the retinoblastoma\u2013E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med. 2000;6(10):1121\u20137. https:\/\/doi.org\/10.1038\/80459.","journal-title":"Nat Med"},{"issue":"6590","key":"9684_CR152","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/382410a0","volume":"382","author":"Y Chang","year":"1996","unstructured":"Chang Y, Moore P, Talbot S, et al. Cyclin encoded by KS herpesvirus. Nature. 1996;382(6590):410. https:\/\/doi.org\/10.1038\/382410a0.","journal-title":"Nature"},{"issue":"11","key":"9684_CR153","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/ncb1980","volume":"11","author":"JS Lee","year":"2009","unstructured":"Lee JS, Li Q, Lee JY, et al. FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol. 2009;11(11):1355\u201362. https:\/\/doi.org\/10.1038\/ncb1980.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"9684_CR154","first-page":"e1011881","volume":"20","author":"ET Kim","year":"2024","unstructured":"Kim ET, Lee H, Oh J, Kim Y, Ahn JH. Human cytomegalovirus degrades SMC5\/6 to recruit cohesin and promote viral transcription. PLoS Pathog. 2024;20(4):e1011881.","journal-title":"PLoS Pathog"},{"issue":"23","key":"9684_CR155","doi-asserted-by":"publisher","first-page":"11880","DOI":"10.1128\/JVI.76.23.11880-11888.2002","volume":"76","author":"H Li","year":"2002","unstructured":"Li H, Komatsu T, Dezube BJ, Kaye KM. The Kaposi\u2019s sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol. 2002;76(23):11880\u20138. https:\/\/doi.org\/10.1128\/JVI.76.23.11880-11888.2002.","journal-title":"J Virol"},{"issue":"5","key":"9684_CR156","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb2054","volume":"12","author":"D Lagos","year":"2010","unstructured":"Lagos D, Pollara G, Henderson S, et al. MiR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol. 2010;12(5):513\u20139. https:\/\/doi.org\/10.1038\/ncb2054.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"9684_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/v16121900","volume":"16","author":"S Komaki","year":"2024","unstructured":"Komaki S, Inagaki T, Kumar A, Izumiya Y. The role of vIL-6 in KSHV-mediated immune evasion and tumorigenesis. Viruses. 2024;16(12):1900. https:\/\/doi.org\/10.3390\/v16121900.","journal-title":"Viruses"},{"key":"9684_CR158","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fmicb.2012.00044","volume":"3","author":"HR Lee","year":"2012","unstructured":"Lee HR, Brulois K, Wong L, Jung JU. Modulation of the immune system by Kaposi\u2019s sarcoma-associated herpesvirus: lessons from viral evasion strategies. Front Microbiol. 2012;3:44. https:\/\/doi.org\/10.3389\/fmicb.2012.00044.","journal-title":"Front Microbiol"},{"issue":"Pt 7","key":"9684_CR159","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1099\/vir.0.81919-0","volume":"87","author":"SA Rezaee","year":"2006","unstructured":"Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. Kaposi\u2019s sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol. 2006;87(Pt 7):1781\u2013804. https:\/\/doi.org\/10.1099\/vir.0.81919-0.","journal-title":"J Gen Virol"},{"issue":"6","key":"9684_CR160","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.molimm.2006.05.012","volume":"44","author":"A Zaldumbide","year":"2007","unstructured":"Zaldumbide A, Ossevoort M, Wiertz EJ, Hoeben RC. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpesvirus. Mol Immunol. 2007;44(6):1352\u201360. https:\/\/doi.org\/10.1016\/j.molimm.2006.05.012.","journal-title":"Mol Immunol"},{"key":"9684_CR161","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nm0498-435","volume":"4","author":"H Lee","year":"1998","unstructured":"Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Karposi\u2019s sarcoma-associated herpesvirus. Nat Med. 1998;4:435\u201340. https:\/\/doi.org\/10.1038\/nm0498-435.","journal-title":"Nat Med"},{"key":"9684_CR162","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1158\/0008-5472.can-03-3653","volume":"64","author":"L Wang","year":"2004","unstructured":"Wang L, et al. The Kaposi\u2019s sarcoma-associated herpesvirus K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 2004;64:2774\u201381. https:\/\/doi.org\/10.1158\/0008-5472.can-03-3653.","journal-title":"Cancer Res"},{"key":"9684_CR163","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00098-15","author":"A Gelgor","year":"2015","unstructured":"Gelgor A, Kalt I, Bergson S, Brulois KF, Jung JU, Sarid R. Viral Bcl-2 encoded by the Kaposi\u2019s sarcoma-associated herpesvirus is vital for virus reactivation. J Virol. 2015. https:\/\/doi.org\/10.1128\/jvi.00098-15.","journal-title":"J Virol"},{"issue":"3","key":"9684_CR164","doi-asserted-by":"publisher","first-page":"e02045","DOI":"10.1128\/JVI.02045-16","volume":"91","author":"X Liu","year":"2017","unstructured":"Liu X, Happel C, Ziegelbauer JM. Kaposi\u2019s sarcoma-associated herpesvirus microRNAs target GADD45B to protect infected cells from cell cycle arrest and apoptosis. J Virol. 2017;91(3):e02045-e2116. https:\/\/doi.org\/10.1128\/JVI.02045-16.","journal-title":"J Virol"},{"issue":"17","key":"9684_CR165","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/01.aids.0000189849.75699.46","volume":"19","author":"SA Rezaee","year":"2005","unstructured":"Rezaee SA, Gracie JA, McInnes IB, Blackbourn DJ. Inhibition of neutrophil function by the Kaposi\u2019s sarcoma-associated herpesvirus vOX2 protein. AIDS. 2005;19(17):1907\u201310. https:\/\/doi.org\/10.1097\/01.aids.0000189849.75699.46.","journal-title":"AIDS"},{"issue":"11","key":"9684_CR166","doi-asserted-by":"publisher","first-page":"9283","DOI":"10.1074\/jbc.m211579200","volume":"278","author":"OB Spiller","year":"2003","unstructured":"Spiller OB, Blackbourn DJ, Mark L, Proctor DG, Blom AM. Functional activity of the complement regulator encoded by Kaposi\u2019s sarcoma-associated herpesvirus. J Biol Chem. 2003;278(11):9283\u20139. https:\/\/doi.org\/10.1074\/jbc.m211579200.","journal-title":"J Biol Chem"},{"issue":"1","key":"9684_CR167","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.043","volume":"3","author":"C Quadrelli","year":"2011","unstructured":"Quadrelli C, Barozzi G, Riva D, et al. \u03b2-HHVs and HHV-8 in lymphoproliferative disorders. Mediterr J Hematol Infect Dis. 2011;3(1):e2011043. https:\/\/doi.org\/10.4084\/MJHID.2011.043.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"20","key":"9684_CR168","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569.","journal-title":"Blood"},{"issue":"9","key":"9684_CR169","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","volume":"100","author":"MQ Du","year":"2002","unstructured":"Du MQ, Diss TC, Liu H, et al. Kaposi sarcoma herpesvirus- and Epstein-Barr virus-associated germinotropic lymphoproliferative disorder. Blood. 2002;100(9):3415\u20138. https:\/\/doi.org\/10.1182\/blood-2002-02-0487.","journal-title":"Blood"},{"issue":"1","key":"9684_CR170","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.hoc.2017.09.007","volume":"32","author":"K Lurain","year":"2018","unstructured":"Lurain K, Yarchoan R, Uldrick TS. Treatment of Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Hematol Oncol Clin North Am. 2018;32(1):75\u201388. https:\/\/doi.org\/10.1016\/j.hoc.2017.09.007.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"9684_CR171","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.biocel.2005.01.018","volume":"37","author":"A Gessain","year":"2005","unstructured":"Gessain A, Duprez R. Spindle cells and their role in Kaposi\u2019s sarcoma. Int J Biochem Cell Biol. 2005;37(12):2457\u201365. https:\/\/doi.org\/10.1016\/j.biocel.2005.01.018.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"9684_CR172","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3322\/canjclin.32.6.342","volume":"32","author":"M Kaposi","year":"1982","unstructured":"Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. CA Cancer J Clin. 1982;32(6):342\u20137. https:\/\/doi.org\/10.3322\/canjclin.32.6.342.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"9684_CR173","doi-asserted-by":"publisher","first-page":"e1008681","DOI":"10.1371\/journal.ppat.1008681","volume":"16","author":"SJ Lidenge","year":"2020","unstructured":"Lidenge SJ, Kossenkov AV, Tso PY, Wickramasinghe J. Comparative transcriptome analysis of endemic and epidemic Kaposi\u2019s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis. PLoS Pathog. 2020;16(7):e1008681. https:\/\/doi.org\/10.1371\/journal.ppat.1008681.","journal-title":"PLoS Pathog"},{"key":"9684_CR174","unstructured":"Leukemia & Lymphoma Society. Non-Hodgkin Lymphoma Subtypes. https:\/\/lls.org\/lymphoma\/non-hodgkin-lymphoma\/nhl-subtypes. Accessed March 1, 2024."},{"issue":"1","key":"9684_CR175","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2004-11-4278","volume":"107","author":"WH Navarro","year":"2006","unstructured":"Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006;107(1):13\u201320. https:\/\/doi.org\/10.1182\/blood-2004-11-4278.","journal-title":"Blood"},{"issue":"2","key":"9684_CR176","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","volume":"88","author":"RG Nador","year":"1996","unstructured":"Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpesvirus. Blood. 1996;88(2):645\u201356. https:\/\/doi.org\/10.1182\/blood.V88.2.645.bloodjournal882645.","journal-title":"Blood"},{"issue":"7","key":"9684_CR177","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00520-002-0363-2","volume":"10","author":"AH Harris","year":"2002","unstructured":"Harris AH, Osborne RH, Streeton CL, McNeil H. Quality of life and Kaposi sarcoma: using preference techniques to value the health gains from treatment. Support Care Cancer. 2002;10(7):486\u201393. https:\/\/doi.org\/10.1007\/s00520-002-0363-2.","journal-title":"Support Care Cancer"},{"issue":"4","key":"9684_CR178","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::aid-cncr2820090430>3.0.co;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822\u201330. https:\/\/doi.org\/10.1002\/1097-0142(195607\/08)9:4%3c822::aid-cncr2820090430%3e3.0.co;2-4.","journal-title":"Cancer"},{"issue":"2","key":"9684_CR179","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s0046-8177(85)80065-4","volume":"16","author":"DD Weisenburger","year":"1985","unstructured":"Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol. 1985;16(2):162\u201372. https:\/\/doi.org\/10.1016\/s0046-8177(85)80065-4.","journal-title":"Hum Pathol"},{"issue":"5","key":"9684_CR180","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/CCO.0b013e328349c233","volume":"23","author":"D Reddy","year":"2011","unstructured":"Reddy D, Mitsuyasu R. HIV-associated multicentric Castleman disease. Curr Opin Oncol. 2011;23(5):475\u201381. https:\/\/doi.org\/10.1097\/CCO.0b013e328349c233.","journal-title":"Curr Opin Oncol"},{"issue":"19","key":"9684_CR181","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1182\/sangue-2008-12-197053","volume":"113","author":"M Bower","year":"2009","unstructured":"Bower M, Veraitch O, Szydlo R, et al. Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease. Blood. 2009;113(19):4521\u20134. https:\/\/doi.org\/10.1182\/sangue-2008-12-197053.","journal-title":"Blood"},{"key":"9684_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00073","volume":"3","author":"MN Polizzotto","year":"2012","unstructured":"Polizzotto MN, Uldrick TS, Hu D, Yarchoan R. Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV\u2013MCD) and the KSHV inflammatory cytokine syndrome. Front Microbiol. 2012;3:73. https:\/\/doi.org\/10.3389\/fmicb.2012.00073.","journal-title":"Front Microbiol"},{"issue":"6","key":"9684_CR183","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1182\/bloodadvances.2020004058","volume":"5","author":"R Ramaswami","year":"2021","unstructured":"Ramaswami R, Lurain K, Polizzotto MN, et al. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases. Blood Adv. 2021;5(6):1660\u201370. https:\/\/doi.org\/10.1182\/bloodadvances.2020004058.","journal-title":"Blood Adv"},{"key":"9684_CR184","unstructured":"American Cancer Society. Understanding Cancer: About Kaposi Sarcoma. https:\/\/www.cancer.org\/cancer\/kaposi-sarcoma\/about.html. Accessed March 13, 2024."},{"key":"9684_CR185","unstructured":"International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 100B: A Review of Human Carcinogens \u2013 Biological Agents. Lyon (France): IARC; 2012. p. 255\u2013285. Available from: https:\/\/publications.iarc.fr\/120"},{"issue":"4","key":"9684_CR186","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.dsi.2018.06.005","volume":"36","author":"B Cetin","year":"2018","unstructured":"Cetin B, Akta\u015f B, Bal O, Algin E, et al. Classic Kaposi\u2019s sarcoma: a review of 156 cases. Turk J Pathol. 2018;36(4):185\u20139. https:\/\/doi.org\/10.1016\/j.dsi.2018.06.005.","journal-title":"Turk J Pathol"},{"issue":"10190","key":"9684_CR187","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/S0140-6736(19)31148-1","volume":"393","author":"YT Qian","year":"2019","unstructured":"Qian YT, Ma DL. Atypical presentation of classic Kaposi\u2019s sarcoma. Lancet. 2019;393(10190):2521. https:\/\/doi.org\/10.1016\/S0140-6736(19)31148-1.","journal-title":"Lancet"},{"issue":"5","key":"9684_CR188","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijid.2005.02.004","volume":"9","author":"S Mohanna","year":"2005","unstructured":"Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi\u2019s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis. 2005;9(5):239\u201350. https:\/\/doi.org\/10.1016\/j.ijid.2005.02.004.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"9684_CR189","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030872","volume":"15","author":"PE Zeinaty","year":"2023","unstructured":"Zeinaty PE, Lebb\u00e9 C, Delyon J. Endemic Kaposi\u2019s sarcoma. Cancers (Basel). 2023;15(3):872. https:\/\/doi.org\/10.3390\/cancers15030872.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"9684_CR190","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5001\/omj.2018.61","volume":"33","author":"GD Forae","year":"2018","unstructured":"Forae GD, Obaseki DE. Trends and histopathological patterns of Kaposi sarcoma at the University of Benin Teaching Hospital, Benin City, Nigeria. Oman Med J. 2018;33(4):337\u201341. https:\/\/doi.org\/10.5001\/omj.2018.61.","journal-title":"Oman Med J"},{"issue":"1","key":"9684_CR191","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41409-019-0644-8","volume":"55","author":"S Cesaro","year":"2020","unstructured":"Cesaro S, Tridello G, van der Werf S, et al. Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT. Bone Marrow Transplant. 2020;55(1):110\u20136. https:\/\/doi.org\/10.1038\/s41409-019-0644-8.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"9684_CR192","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4103\/ijd.IJD_217_18","volume":"64","author":"C Baykal","year":"2019","unstructured":"Baykal C, Atci T, Buyukbabani N, Kutlay A. The spectrum of underlying causes of iatrogenic Kaposi\u2019s sarcoma in a large series: a retrospective study. Indian J Dermatol. 2019;64(5):392\u20139. https:\/\/doi.org\/10.4103\/ijd.IJD_217_18.","journal-title":"Indian J Dermatol"},{"issue":"9","key":"9684_CR193","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/infdis\/jiv235","volume":"212","author":"K Djawe","year":"2015","unstructured":"Djawe K, Buchacz K, Hsu L, Chen MJ, Selik RM, Rose C, et al. Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons\u2014San Francisco, 1981\u20132012. J Infect Dis. 2015;212(9):1366\u201375. https:\/\/doi.org\/10.1093\/infdis\/jiv235.","journal-title":"J Infect Dis"},{"issue":"1","key":"9684_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-3-31","volume":"3","author":"W Grayson","year":"2008","unstructured":"Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3(1):31.","journal-title":"Diagn Pathol"},{"issue":"10","key":"9684_CR195","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.annder.2017.09.593","volume":"145","author":"M Chapalain","year":"2018","unstructured":"Chapalain M, Goldman-L\u00e9vy G, Kramkimel N, et al. Anaplastic Kaposi\u2019s sarcoma: 5 cases of a rare and aggressive type of Kaposi\u2019s sarcoma. Ann Dermatol Venereol. 2018;145(10):633\u20138. https:\/\/doi.org\/10.1016\/j.annder.2017.09.593.","journal-title":"Ann Dermatol Venereol"},{"key":"9684_CR196","unstructured":"International Agency for Research on Cancer (IARC). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC; 2013. Available from: http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_population.aspx. Accessed March 1, 2024."},{"issue":"3","key":"9684_CR197","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"9684_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87038-9","volume":"11","author":"AD Lopes","year":"2021","unstructured":"Lopes AD, Spitz N, Reis CR, et al. Update of the global distribution of human gammaherpesvirus 8 genotypes. Sci Rep. 2021;11:7640. https:\/\/doi.org\/10.1038\/s41598-021-87038-9.","journal-title":"Sci Rep"},{"key":"9684_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-017-0142-9","volume":"12","author":"T Zhang","year":"2017","unstructured":"Zhang T, Liu Z, Wang J, et al. Seroprevalence of antibodies against Kaposi\u2019s sarcoma-associated herpesvirus among HIV-negative people in China. Infect Agents Cancer. 2017;12:32. https:\/\/doi.org\/10.1186\/s13027-017-0142-9.","journal-title":"Infect Agents Cancer"},{"issue":"3","key":"9684_CR200","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/scbi.1998.0089","volume":"9","author":"LG Chatlynne","year":"1999","unstructured":"Chatlynne LG, Ablashi DV. Seroepidemiology of Kaposi\u2019s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol. 1999;9(3):175\u201385. https:\/\/doi.org\/10.1006\/scbi.1998.0089.","journal-title":"Semin Cancer Biol"},{"key":"9684_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104986","author":"H Lambarey","year":"2024","unstructured":"Lambarey H, Blumenthal MJ, Chetram A, et al. Reactivation of Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients. EBioMedicine. 2024. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104986.","journal-title":"EBioMedicine"},{"issue":"3","key":"9684_CR202","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/QAI.0000000000000862","volume":"71","author":"E Amerson","year":"2016","unstructured":"Amerson E, Woodruff CM, Forrestel A, et al. Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in East Africa. J Acquir Immune Defic Syndr. 2016;71(3):295\u2013301. https:\/\/doi.org\/10.1097\/QAI.0000000000000862.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"9684_CR203","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.abd.2021.02.008","volume":"96","author":"AL Sampaio","year":"2021","unstructured":"Sampaio AL, Bressan AL, Vasconcelos BN, Gripp AC. Skin manifestations associated with systemic diseases \u2013 Part I. An Bras Dermatol. 2021;96(6):655\u201371. https:\/\/doi.org\/10.1016\/j.abd.2021.02.008.","journal-title":"An Bras Dermatol"},{"key":"9684_CR204","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12981-020-00312-0","volume":"17","author":"P Mo","year":"2020","unstructured":"Mo P, Deng L, Chen X, et al. Rapid progression of Kaposi\u2019s sarcoma complicated with hemophagocytic syndrome in a severely immunosuppressed patient with HIV-infection: a case report. AIDS Res Ther. 2020;17:58. https:\/\/doi.org\/10.1186\/s12981-020-00312-0.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"9684_CR205","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mpdhp.2021.10.005","volume":"28","author":"R Wadee","year":"2022","unstructured":"Wadee R, Grayson W. Cutaneous Kaposi sarcoma and its mimics. Diagn Histopathol. 2022;28(1):38\u201352. https:\/\/doi.org\/10.1016\/j.mpdhp.2021.10.005.","journal-title":"Diagn Histopathol"},{"issue":"23","key":"9684_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235927","volume":"13","author":"N Dupin","year":"2021","unstructured":"Dupin N, Jary A, Boussouar S, et al. Current and future tools for diagnosis of Kaposi\u2019s sarcoma. Cancers (Basel). 2021;13(23):5927. https:\/\/doi.org\/10.3390\/cancers13235927.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"9684_CR207","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/153303460400300506","volume":"3","author":"M Hassan","year":"2004","unstructured":"Hassan M, Little RF, Vogel A, et al. Quantitative assessment of tumor vasculature and response to therapy in Kaposi\u2019s sarcoma using functional noninvasive imaging. Technol Cancer Res Treat. 2004;3(5):451\u20137. https:\/\/doi.org\/10.1177\/153303460400300506.","journal-title":"Technol Cancer Res Treat"},{"issue":"9","key":"9684_CR208","doi-asserted-by":"publisher","first-page":"e0163616","DOI":"10.1371\/journal.pone.0163616","volume":"11","author":"L Cathy","year":"2016","unstructured":"Cathy L, Kathryn T, Suzanne PF, et al. Rapid multiplexed immunoassay for detection of antibodies to Kaposi\u2019s sarcoma-associated herpesvirus. PLoS ONE. 2016;11(9):e0163616. https:\/\/doi.org\/10.1371\/journal.pone.0163616.","journal-title":"PLoS ONE"},{"issue":"9","key":"9684_CR209","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","volume":"7","author":"SE Krown","year":"1989","unstructured":"Krown SE, Metroka C, Wernz JC. Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol. 1989;7(9):1201\u20137. https:\/\/doi.org\/10.1200\/JCO.1989.7.9.1201.","journal-title":"J Clin Oncol"},{"issue":"5","key":"9684_CR210","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1200\/JCO.2013.51.6757","volume":"32","author":"M Bower","year":"2014","unstructured":"Bower M, DallaPria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi\u2019s sarcoma: results from a multicentre cohort study. J Clin Oncol. 2014;32(5):409\u201314. https:\/\/doi.org\/10.1200\/JCO.2013.51.6757.","journal-title":"J Clin Oncol"},{"issue":"14","key":"9684_CR211","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1128\/JVI.01603-05","volume":"80","author":"C Grossmann","year":"2006","unstructured":"Grossmann C, Podgrabinska S, Skobe M, Ganem D. Activation of NF-kappaB by the latent vFLIP gene of Kaposi\u2019s sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol. 2006;80(14):7179\u201385. https:\/\/doi.org\/10.1128\/JVI.01603-05.","journal-title":"J Virol"},{"key":"9684_CR212","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41467-024-45852-5","volume":"15","author":"Q Wan","year":"2024","unstructured":"Wan Q, Tavakoli L, Wang TY, et al. Nucleotide biosynthesis and glycolysis hijacking via viral deamidation by an oncogenic herpesvirus. Nat Commun. 2024;15:1442. https:\/\/doi.org\/10.1038\/s41467-024-45852-5.","journal-title":"Nat Commun"},{"issue":"3","key":"9684_CR213","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1086\/654798","volume":"51","author":"TS Uldrick","year":"2010","unstructured":"Uldrick TS, Wang V, O\u2019Mahony D, et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma\u2013associated herpesvirus and HIV but without multicentric Castleman disease. Clin Infect Dis. 2010;51(3):350\u20138. https:\/\/doi.org\/10.1086\/654798.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"9684_CR214","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1681\/ASN.2005090993","volume":"17","author":"JM Campistol","year":"2006","unstructured":"Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol. 2006;17(2):581\u20139. https:\/\/doi.org\/10.1681\/ASN.2005090993.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"9684_CR215","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaad.2008.05.001","volume":"59","author":"RA Schwartz","year":"2008","unstructured":"Schwartz RA, Micali G, Nasca MR, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59(2):179\u2013206. https:\/\/doi.org\/10.1016\/j.jaad.2008.05.001.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9684_CR216","first-page":"109","volume":"25","author":"AR Travassos","year":"2010","unstructured":"Travassos AR, Costa JB, Uva L, et al. Endemic African Kaposi\u2019s sarcoma: a description of the clinical features and therapeutic options in three patients. Skin Cancer. 2010;25(2):109\u201316.","journal-title":"Skin Cancer"},{"issue":"11","key":"9684_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112519","volume":"13","author":"L Benajiba","year":"2021","unstructured":"Benajiba L, Lambert J, La Selva R, et al. Systemic treatment initiation in classical and endemic Kaposi\u2019s sarcoma: risk factors and global multi-state modelling in a monocentric cohort study. Cancers (Basel). 2021;13(11):2519. https:\/\/doi.org\/10.3390\/cancers13112519.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"9684_CR218","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/09546634.2019.1590520","volume":"30","author":"A Tourlaki","year":"2019","unstructured":"Tourlaki A, Germiniasi F, Rossi LC, et al. Paclitaxel as first- or second-line treatment for HIV-negative Kaposi\u2019s sarcoma: a retrospective study of 58 patients. J Dermatol Treat. 2019;30(2):183\u20135. https:\/\/doi.org\/10.1080\/09546634.2019.1590520.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"9684_CR219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006100","volume":"13","author":"HS Chen","year":"2017","unstructured":"Chen HS, De Leo A, Wang Z, Kerekovic A, Hills R, Lieberman PM. BET-inhibitors disrupt Rad21-dependent conformational control of KSHV latency. PLoS Pathog. 2017;13(1):e1006100. https:\/\/doi.org\/10.1371\/journal.ppat.1006100.","journal-title":"PLoS Pathog"},{"issue":"4","key":"9684_CR220","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1470-2045(22)00097-3","volume":"23","author":"J Delyon","year":"2022","unstructured":"Delyon J, Biard L, Renaud M, Resche-Rigon M, Le Goff J, Dalle S, et al. PD-1 blockade with pembrolizumab in classic or endemic Kaposi\u2019s sarcoma: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2022;23(4):491\u2013500. https:\/\/doi.org\/10.1016\/S1470-2045(22)00097-3.","journal-title":"Lancet Oncol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09684-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:15Z","timestamp":1770190155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09684-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":220,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9684"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09684-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is a revision manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}